ArticleBioinformation2025
Comparative evaluation of crestal bone loss around dental implants following platelet concentrates and beta TCP bone graft.
Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The degree of crestal bone loss surrounding dental implants (mare than 0.2 mm) significantly affects their success rate. So, the crestal bone loss surrounding dental implants following the implantation of platelet concentrates and beta-tricalcium phosphate bone grafts was compared. In 100 subjects, two implants each were placed in edentulous spaces where one implant site of Group I was filled with β-Tricalcium Phosphate Bone Graft along (β-TCP) with platelet-rich plasma (PRP) and for Group II only β-Tricalcium Phosphate Bone Graft along (β-TCP) was placed in posterior edentulous area and followed for 3, 6 and 9 months using periapical radiographs. In both groups, the highest mean crestal bone loss was highest on the lingual side of the implant. Adding PRP (platelet rich plasma) to beta tricalcium phosphate helps in reduced bone loss in dental implants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.